Wednesday, 20 March, 2024

Cure51 Secures €15M Seed Round to Advance Cancer Survival Research

Cure51 successfully raises a €15 million seed funding round with the goal of advancing cancer survival research. The startup aims to decode the complexities of cancer treatment and improve patient outcomes. With this funding, Cure51 intends to accelerate its efforts in developing innovative therapies and treatment strategies, ultimately contributing to the fight against cancer and offering hope to patients worldwide.